As of today (2024-05-16), the Forward Annual Dividend Yield of Alliance Pharma is 0.00%.
As of today (2024-05-16), the Trailing Annual Dividend Yield of Alliance Pharma is 3.36%.
LSE:APH's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.85 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 12 months, Alliance Pharma's average Dividends Per Share Growth Rate was 5.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 4.30% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 5.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Alliance Pharma was 100.00% per year. The lowest was -27.30% per year. And the median was 8.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Alliance Pharma's Forward Dividend Yield %
For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alliance Pharma's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Alliance Pharma's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Alliance Pharma Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
GBP 0.011840
2023-06-22
2023-06-23
2023-07-18
Cash Dividend
semi-annually
GBP:GBP 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Alliance Pharma's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Alliance Pharma Forward Dividend Yield % Related Terms
Thank you for viewing the detailed overview of Alliance Pharma's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:APH has been successfully added to your